Medical Supplies

November 2008
M	T	W	T	F	S	S
« Sep
	1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

LEA Medizintechnik GmbH

June 30th, 2008 — admin

Winchester Straße 2
35394 Gießen
Germany

Phone: (+49-641)96988-0
Fax: (+49-641)96988-12
http://www.lea.de
info@lea.de

Company Contacts
Department/ Name Address

Dr. Alfons Krug LEA Medizintechnik GmbH, Winchesterstrasse 2, 35394 Giessen, Tel: ++49 641 969880, info@lea.de
Info@lea.de

Company Figures
Number of employees 1-19
Sales volume 1-9 Mio US $
Export content max. 25%
Year of foundation 1995
Area of business Electronical Equipment / Medical Technology

Language: German Language: English Company Profile

LEA Medizintechnik GmbH

History
LEA was founded in 1995 with the objective of transferring new optical methods for non-invasive investigation of vital parameters from intensive clinical research into products with strong demand on the clinical market. LEA has many years of experience in developing sensor technology, measurement probes, flexible software solutions, ergonomic, customer oriented user interfaces and in producing PC supported diagnostic devices. The technical basis of the devices has been developed and verified by an high qualified team of engineers, technicians, human biologists and physicians in cooperation with research facilities and hospitals. Up to now LEA and its partners have applied altogether for five patents of hardware and measuring methods resp. acquired the rights for them (mostly worldwide). Furthermore four brands (OptoFlow, AbTisSpec, O2C and CytoSpec) had been registered. Essential for the competitive advantage is the know how which is reflected by the self developed theoretical models and the interpretation of the measured values. This knowledge is, to the bigger part, protected knowledge of the company and generates an important basis for the current development. New studies are permanently carried out with LEA devices. Some are already completed and published and therewith they are showing steadily new fields of application. The close contact to hospitals and the permanent feedback of the users permit an optimal, application-oriented development of our devices.
Philosophy
A basic characteristic of the organisation of LEA is the close interlocking of the subjects of medicine, engineering, marketing and distribution. LEA employs employees from the subjects of human biology, medicine, electrical engineering, medical engineering, informatics and business economics. The knowledge and qualification of each is supplemented by the training of each in each other subject. This ensures an optimal feedback between the employees. Thus a very close connection between development, production and distribution is created, in order to react to a shift of the market and to factor the customer wishes into the Development. A flat hierarchical structure allows that the whole process flow can be seen through by a single employee, which is an unbeatable advantage for an unbureaucratic problem solving, to the benefit of the customer. The benefit of the customer and a prompt and reliable solution of his problems have top priority for LEA. For the assurance of highest demands on quality our company is accredited according to DIN ISO 9001 and ISO 13485 and our devices are up to standard to MPG (the german medical device act which is enforcing the medical device directive 93/42/EEC).
Innovation / Perspectives
LEA occupies a top position by worldwide unique characteristics of its products and proceedings, globally secured by patents. LEA devices allow a non-invasive measurement of blood circulation, oxygen saturation and, for the first time, the oxygen consumption in several tissue depths. Thus it is possible to measure the tissue vitality as well as the muscle movements in realtime without big devices. The intention of our company is to achieve the market leadership for non-invasive optical sensors for the measurement of oxygen supply in tissue, in Europe and the U.S. This is provided by a permanent extension of the distribution network, both in direct distribution and with an increasing number of highly motivated distribution partners. A permanent extension of the fields of application is provided by several studies in Europe and the U.S. By now there are studies with LEA devices in many fields of application like plastic surgery, vascular surgery, diabetes, abdominal surgery, wound healing (CVI, ulcera, etc.), intensive care (patient monitoring), transplantation, therapy control and cardiac surgery. LEA continues to make assiduous efforts to realize customer loyalty by upgrading the device service and guidance and application guidance. This is provided by a highly adaptive evaluation tool and a range of services. In the future LEA will enter the market as a service provider with flexible software tools. These software tools are adapted for customized wishes and problems of data evaluation. They offer solutions for data interfaces, signal processing, source of error analysis and the entire statistics and archival storage. The supply of services will reach from study design and study evaluation to the solution of data archiving.

Product Information
01.01.02.02 Blood flow measurement equipment
USCOM 03.09.2007

The USCOM non-invasive cardiac output monitor uses state-of-the art electronics, ultrasonics and signal processing to deliver a cutting edge solution to the challenge of accurately measuring cardiac flow.
The USCOM monitor provides an intuitive touch screen user interface, allowing for instant access to both live and recorded information.
In addition to the display of real-time information, the system provides for the recording of measure cards, a detailed record of beat-to-beat cardiac function. By accurately measuring change, USCOM is the ideal patient management tool.

With a 20GB hard drive, the USCOM monitor can store tens-of-thousands of patient files.

Weighing just 6 kilograms and available with its own custom roll stand, the USCOM system is highly portable, ideal for transfer from patient-to-patient or ward-to-ward.

01.01.02.02.01 Measuring devices for blood congestion
O2C (oxygen to see) 03.09.2007

The O2C (oxygen to see) allows a non-invasive measurement of capillary Blood Flow, capillary-venous Oxygen Saturation and, for the first time, the Oxygen Consumption. Thus it is possible to measure the Tissue Vitality as well as the muscle function in real-time by an flexible probe. Further the measurement of the filling of venules with blood and the vascular density (angiogenesis).

The devices with the name O2C (oxygen to see) are applied for monitoring of skin/muscle flaps, control of peripheral hypoxia, in wounds, disorder of micro-circulation (diabetes), organ-transplants, at bones, determination of amputation level, chronic venous insufficiency, peripheral arterial diseases, Sepsis (mucosal monitoring), determination of ischemic, hypoxia and metabolic disorders in tissue, for therapy control, in animal experiments, just to name a few core applications.